Product
NNC0471-0119
2 clinical trials
2 indications
Indication
Diabetes MellitusIndication
Type 1Clinical trial
A Trial Investigation the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Subcutaneous NNC0471-0119 in Subjects With Type 1 Diabetes MellitusStatus: Completed, Estimated PCD: 2021-11-26
Clinical trial
A Study Investigating the Pharmacokinetic and Pharmacodynamic Properties and Safety and Tolerability of Three Formulations of NNC0471-0119 When Administered as One Bolus in a Continuous Subcutaneous Insulin Infusion Regimen in Participants With Type 1 DiabetesStatus: Completed, Estimated PCD: 2022-08-29